HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J. D. Articles by Park, C. Y. Search for Related Content PubMed PubMed Citation Articles by Lee, J. D. Articles by Park, C. Y.

Indium-111-Pentetreotide Imaging in Intra-axial Brain Tumors: Comparison with Thallium-201 SPECT and MRI

Departments of Diagnostic Radiology and Neurosurgery, Yonsei University, College of Medicine, Seoul, Korea

Correspondence: For correspondence or reprints contact: J. D. Lee, MD, Department of Diagnostic Radiology, Yonsei University, College of Medicine, 134 Shincheon-dong, Seodaemun-gu, Seoul, 120-752, Korea.

ABSTRACT

Highly undifferentiated glial tumors do not express somatostatin receptors (SSR) in contrast to low-grade astrocytomas which contain SSR. To differentiate a malignant glioma from a low-grade astrocytoma and to distinguish an SSR-positive intra-axial brain tumor from an SSR negative one, ¹¹¹In-pentetreotide brain SPECT was prospectively undertaken. Methods: Eight patients with intra-axial brain tumors (three glioblastoma multiforme, one low-grade astrocytoma, one lymphoma, one medulloblastoma, one neurocytoma and one metastatic tumor) were studied. Thallium-201 and ¹¹¹In-pentetreotide brain SPECT were performed with a 3- to 4-day interval before surgery. The SPECT findings were compared with those of Gd-enhanced MRI. Results: Increased uptake of ¹¹¹In-pentetreotide was observed in all of the patients with glioblastoma multiforme (Grade +++ in two and Grade + in one) despite lack of SSR. Low-grade astrocytoma exhibited minimal uptake of ¹¹¹In-pentetreotide (Grade +). Remaining tumors had intense uptake of ¹¹¹In-pentetreotide. Thallium-201 SPECT showed similar findings to those of ¹¹¹In-pentetreotide scintigraphy except in two patients with glioblastoma multiforme: One with ²⁰¹Tl negative scan showed increased uptake of ¹¹¹In-pentetreotide and the other showed increased thallium uptake but minimal uptake of ¹¹¹In-pentetreotide. The uptake pattern of both ²⁰¹Tl and ¹¹¹In-pentetreotide appeared to correlate with Gd-enhanced MRI. Conclusion: Indium-111-pentetreotide scintigraphy is sensitive in the detection of intra-axial brain tumors; however, it has no role in assessing the tumor grading and in the definition of the receptor profile.

Key Words: brain tumors • indium-111-pentetreotide • thallium-201 • SPECT • somatostatin • magnetic resonance imaging

This article has been cited by other articles:

				G. Khanna, D. Bushnell, and M. S. O'Dorisio Utility of Radiolabeled Somatostatin Receptor Analogues for Staging/Restaging and Treatment of Somatostatin Receptor-Positive Pediatric Tumors Oncologist, April 1, 2008; 13(4): 382 - 389. [Abstract] [Full Text] [PDF]

				M J Acosta-Gomez, M A Muros, J M Llamas-Elvira, A Ramirez, S Ortega, G Sabatel, C Ramos, and A de la Riva-Aguilar The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours Br. J. Radiol., February 1, 2005; 78(926): 110 - 115. [Abstract] [Full Text] [PDF]